Tech Company Financing Transactions
TNG Pharmaceuticals Funding Round
TNG Pharmaceuticals secured a $4.6 million Series A investment round on 2/10/2014. Backers included Angel Investor Management Group, Bluegrass Angels and Commonwealth Capital Ventures.
Transaction Overview
Company Name
Announced On
2/10/2014
Transaction Type
Venture Equity
Amount
$4,600,000
Round
Series A
Investors
Proceeds Purpose
This important round of funding will allow us to complete all phases of product development necessary to commercialize the vaccine in a timely fashion.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 East Jefferson St. 201
Louisville, KY 40202
USA
Louisville, KY 40202
USA
Phone
Website
Email Address
Overview
TNG Pharmaceuticals began at the University of Louisville in the Entrepreneurship MBA program. TNG competed on a global business plan competition circuit: winning four of five competitions, including the world's largest, richest, and most prestigious competitions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Serge Martinod
Co-Founder
Jenny Corbin
Co-Founder
Larry Horn
Browse more venture capital transactions:
Prev: 2/10/2014: UpTo venture capital transaction
Next: 2/10/2014: MassRoots venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs